Presentation Information
[O3-04]SARS-COV2mRNA脂質ナノ粒子製剤接種後症候群(PVS)の実態と臨床的特徴
〜全国14施設レジストリによる多症状・長期化の検討〜
*Akinori Fujisawa1, Shinichiro Kodama2, Nafuko Konishi3, Jun Ueda4, Eiji Nakatani5, Masanori Fukushima6 (1. Kokoro Medical Corporation, Honbetsu Cardiovascular Medicine Clinic, 2. Kodama Hospital & Kodama Medical Office, 3. Viola Clinic, 4. Department of Advanced Medical Science, Asahikawa Medical University, 5. Department of Biostatistics and Health Data Science, Graduate School of Medical Science Nagoya City University, 6. Learning Health Society Institute)